GWS
SGMO

Glassman Wealth Services’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Glassman Wealth Services’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-713
Closed -$1.25K – 1999
2023
Q1 		$1.25K Buy
+713
New +$2.04K ﹤0.01% 1363
2020
Q1 		– Sell
-3
Closed – – 1514
2019
Q4 		$0 Buy
+3
New +$28 ﹤0.01% 1452

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glassman Wealth Services's SGMO Position: Q2 2023 in Review

Glassman Wealth Services sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 713 shares — an estimated $1.25K sold.

Glassman Wealth Services first reported a position in SGMO in Q4 2019 and held it in 2 quarters. The position peaked at $1.25K in Q1 2023. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.

  • Glassman Wealth Services reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
  • Glassman Wealth Services sold 713 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $1.25K.
  • Glassman Wealth Services first reported a position in SANGAMO THERAPEUTICS INC in Q4 2019 and held it in 2 quarters.
  • Glassman Wealth Services's SANGAMO THERAPEUTICS INC position peaked at $1.25K in Q1 2023.
  • 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.

Based on Glassman Wealth Services's 13F filing for Q2 2023, filed 8 Aug 2023.